21:24:05 EDT Sun 26 Mar 2023
Enter Symbol
or Name

News for U:DHR from 2022-03-25 to 2023-03-24 - 31 items News ReleasesIn The NewsOther CAUS
2023-03-07 08:00U:DHRNews ReleaseDanaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies
2023-02-22 16:30U:DHRNews ReleaseDanaher Announces Quarterly Dividends
2023-02-08 09:00U:DHRNews ReleaseDanaher Announces New Environmental and Applied Solutions Company to Be Named Veralto
2023-01-24 06:00U:DHRNews ReleaseDanaher Reports Fourth Quarter and Full Year 2022 Results
2023-01-09 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance
2023-01-03 16:30U:DHRNews ReleaseDanaher to Present at J.P. Morgan Healthcare Conference
2022-12-27 16:30U:DHRNews ReleaseDanaher Schedules Fourth Quarter 2022 Earnings Conference Call
2022-12-06 16:20U:DHRNews ReleaseDanaher Announces Quarterly Dividends
2022-11-22 16:45U:DHRNews ReleaseDanaher to Present at Evercore ISI HealthCONx Conference
2022-11-15 07:00U:DHRNews ReleaseCepheid Launches Multiplex Vaginal Panel (MVP) to Support More Accurate Women's Health Diagnosis in U.S.
2022-11-10 16:15U:DHRNews ReleaseDanaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation
2022-10-20 06:00U:DHRNews ReleaseDanaher Reports Third Quarter 2022 Results
2022-10-05 16:30U:DHRNews ReleaseDanaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target
2022-09-20 16:30U:DHRNews ReleaseDanaher Schedules Third Quarter 2022 Earnings Conference Call
2022-09-14 16:15U:DHRNews ReleaseDanaher CEO to Comment on Financial Performance
2022-09-14 16:15U:DHRNews ReleaseDanaher Announces Intention to Separate Environmental & Applied Solutions Segment to Create an Independent, Publicly Traded Company
2022-09-13 16:15U:DHRNews ReleaseDanaher Announces Quarterly Dividends
2022-09-01 17:00U:DHRNews ReleaseDanaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva
2022-07-25 07:41U:DHRNews ReleaseBeckman Coulter Partners with Mass General and BARDA to Identify Severe Pediatric Infections in Emergency Departments
2022-07-21 06:00U:DHRNews ReleaseDanaher Reports Second Quarter 2022 Results
2022-06-29 17:00U:DHRNews ReleaseDanaher Announces Appointment of Feroz Dewan to Danaher Board
2022-06-21 16:30U:DHRNews ReleaseDanaher Schedules Second Quarter 2022 Earnings Conference Call
2022-06-06 12:00U:DHRNews ReleaseSCIEX Launches the Next Generation of Data Independent Acquisition With Zeno SWATH DIA at ASMS 2022
2022-06-06 12:00U:DHRNews ReleaseSCIEX Launches the New Cornerstone of Software Ecosystem - SCIEX OS 3.0
2022-05-12 16:30U:DHRNews ReleaseDanaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases
2022-05-09 11:00U:DHRNews ReleaseRNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics
2022-05-04 16:30U:DHRNews ReleaseDanaher To Present At Bank Of America Securities Health Care Conference
2022-04-21 06:00U:DHRNews ReleaseDanaher Reports First Quarter 2022 Results
2022-04-12 16:30U:DHRNews ReleaseDanaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock
2022-03-28 09:00U:DHRNews ReleaseCatalytic Data Science Joins Integrated DNA Technologies Align Program